News Room - Press Releases (2005)
Expert Advisory Boards Instituted at Nanomix; Scientific, Technical and Medical Advisory Boards Created
EMERYVILLE, California (September 30, 2005) - Nanomix Inc. announces the recent initiation of Advisory Boards to provide additional expertise in scientific, technical and medical areas at Nanomix. These three groups formalize existing relationships and add new leaders to the Nanomix team of advisors.
The Scientific Advisory Board (SAB) consists of Nanomix co-founders and SAB co-chairpersons Dr. Marvin Cohen, University of California, Berkeley and Dr. Alex Zettl, University of California, Berkeley. Also joining the Nanomix SAB is Thomas Kalil, UC Berkeley Office of the Chancellor; and Dr. Carlos Bustamante, University of California, Berkeley. The SAB is focused on identifying and fulfilling fundamental technical requirements for optimizing and leveraging the Sensation™ nanoelectronic detection platform.
The Technical Advisory Board (TAB) consists of Dr. Kris Pister, Dust Networks; Dr. Phillip Collins, University of California, Irvine; Dr. Eric Snow, Naval Research Laboratories; and Dr. Alexander Star, University of Pittsburgh. The TAB provides guidance to Nanomix primarily on the development of specific applications for Sensation™.
The Medical Advisory Board (MAB) consists of Dr. Matthew Lewin, University of California, San Francisco; Dr. Philip Bickler, University of California, San Francisco; and Dr. Mananda Bhende, Children's Hospital of Pittsburgh. The MAB contributes to product definition and customer perspective related to a variety of medical applications enabled by Sensation™ technology.
"We are excited to be working with such a distinguished team of expert advisors to assist us with the commercialization of our products. It is critical for Nanomix to align with leaders in these fields to maximize the development and deployment of Sensation™," stated David Macdonald, President and CEO of Nanomix.
The Scientific Advisory Board (SAB) consists of Nanomix co-founders and SAB co-chairpersons Dr. Marvin Cohen, University of California, Berkeley and Dr. Alex Zettl, University of California, Berkeley. Also joining the Nanomix SAB is Thomas Kalil, UC Berkeley Office of the Chancellor; and Dr. Carlos Bustamante, University of California, Berkeley. The SAB is focused on identifying and fulfilling fundamental technical requirements for optimizing and leveraging the Sensation™ nanoelectronic detection platform.
The Technical Advisory Board (TAB) consists of Dr. Kris Pister, Dust Networks; Dr. Phillip Collins, University of California, Irvine; Dr. Eric Snow, Naval Research Laboratories; and Dr. Alexander Star, University of Pittsburgh. The TAB provides guidance to Nanomix primarily on the development of specific applications for Sensation™.
The Medical Advisory Board (MAB) consists of Dr. Matthew Lewin, University of California, San Francisco; Dr. Philip Bickler, University of California, San Francisco; and Dr. Mananda Bhende, Children's Hospital of Pittsburgh. The MAB contributes to product definition and customer perspective related to a variety of medical applications enabled by Sensation™ technology.
"We are excited to be working with such a distinguished team of expert advisors to assist us with the commercialization of our products. It is critical for Nanomix to align with leaders in these fields to maximize the development and deployment of Sensation™," stated David Macdonald, President and CEO of Nanomix.
About Nanomix
Nanomix is launching a portfolio of devices based on Sensation™ detection technology. These scaleable, nanoelectronic devices use ultra-sensitive carbon nanotube sensing elements combined with proprietary chemistries. These devices can be deployed across a broad range of industrial and medical applications where the attributes of nanodetection technology -- low power consumption, small form factor, and high sensitivity offer significant performance advantages and enable unprecedented access to critical information. Nanomix is located in Emeryville, California. For additional information, please visit the Nanomix web site at www.nano.com.